361 related articles for article (PubMed ID: 26185359)
1. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.
Twigg MS; Brockbank S; Lowry P; FitzGerald SP; Taggart C; Weldon S
Mediators Inflamm; 2015; 2015():293053. PubMed ID: 26185359
[TBL] [Abstract][Full Text] [Related]
2. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies.
Birrer P
Respiration; 1995; 62 Suppl 1():25-8. PubMed ID: 7792437
[TBL] [Abstract][Full Text] [Related]
3. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis.
McGreal EP; Davies PL; Powell W; Rose-John S; Spiller OB; Doull I; Jones SA; Kotecha S
Biochim Biophys Acta; 2010; 1802(7-8):649-58. PubMed ID: 20438838
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.
Hunt AMD; Glasgow AMA; Humphreys H; Greene CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012925
[TBL] [Abstract][Full Text] [Related]
6. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
8. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
Motta JP; Magne L; Descamps D; Rolland C; Squarzoni-Dale C; Rousset P; Martin L; Cenac N; Balloy V; Huerre M; Fröhlich LF; Jenne D; Wartelle J; Belaaouaj A; Mas E; Vinel JP; Alric L; Chignard M; Vergnolle N; Sallenave JM
Gastroenterology; 2011 Apr; 140(4):1272-82. PubMed ID: 21199654
[TBL] [Abstract][Full Text] [Related]
9. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
10. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
11. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
[TBL] [Abstract][Full Text] [Related]
12. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
13. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
14. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors.
Schuster A; Fahy JV; Ueki I; Nadel JA
Eur Respir J; 1995 Jan; 8(1):10-4. PubMed ID: 7744174
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro.
Liu H; Lazarus SC; Caughey GH; Fahy JV
Am J Physiol; 1999 Jan; 276(1):L28-34. PubMed ID: 9887052
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts.
Ferkol T; Cohn LA; Phillips TE; Smith A; Davis PB
Am J Respir Crit Care Med; 2003 May; 167(10):1374-9. PubMed ID: 12615618
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).
Roghanian A; Sallenave JM
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):125-44. PubMed ID: 18518838
[TBL] [Abstract][Full Text] [Related]
20. SLPI and elafin: multifunctional antiproteases of the WFDC family.
Scott A; Weldon S; Taggart CC
Biochem Soc Trans; 2011 Oct; 39(5):1437-40. PubMed ID: 21936829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
